Cutler Group LP Kodiak Sciences Inc. Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$6.52 - $8.05 $652 - $805	-100 Reduced 14.29%	600 $4,000
Q3 2022 Oct 25, 2022	SELL	$7.57 - $12.5 $4,981 - $8,225	-658 Reduced 48.45%	700 $5,000
Q2 2022 Aug 04, 2022	BUY	$5.04 - $9.48 $4,536 - $8,532	900 Added 196.51%	1,358 $10,000
Q1 2022 Apr 14, 2022	BUY	$7.09 - $89.45 $1,829 - $23,078	258 Added 129.0%	458 $3,000
Q2 2020 Jul 22, 2020	BUY	$42.74 - $66.25 $8,548 - $13,250	200 New	200 $10,000

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $288M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.